Latest filing published 31 Jan 2018 for CanniMed Therapeutics Inc., €16k.
Dwayne Lawrence Lashyn is a declared insider of CanniMed Therapeutics Inc., with filings sourced from SEDI. Between 21 December 2016 and 24 January 2018, the trades on record add up to 5 filings.
No open-market sale appears; the market trades are 1 purchase worth €30k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 2 option exercises.
The record was last updated on 31 January 2018 with an option exercise (€16k) in CanniMed Therapeutics Inc. The most recent open-market purchase was published on 30 December 2016, 3,586 days ago. Typically, a trade is published a median of 7 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations